Clinical trial
Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary…
NCT00479895 · Biopure Corporation, Industry · Completed
Key facts
| NCT number | NCT00479895 |
|---|---|
| Title | Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization |
| Official title | Phase II, Open-Label Study in the Catheterization Laboratory Setting to Challenge the Concept That HBOC-201 Administration Might Improve Myocardial 'Oxygenation' and Myocardial Function at the Moment of (Brief) Coronary Occlusion |
| Lead sponsor | Biopure Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Occlusion, Acute Coronary Syndrome |
| Intervention type | Drug |
| Interventions | Hemoglobin Based Oxygen Carrier-201 (HBOC-201, Hemopure) |
| Enrollment | 5 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 28, 2007 |
| Last update posted | May 30, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: